I have a choice between this trial and a BAT trial. I’m already preferential to BAT, but without being too hasty, I wanted to see if anyone here has any experience with JANX00x before deciding.
A Phase 1, Open-Label, Multicenter St... - Advanced Prostate...
A Phase 1, Open-Label, Multicenter Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer
Written by
No_stone_unturned
To view profiles and participate in discussions please or .
Read more about...
4 Replies
•
The immunotherapy trial will cause more side effects than the BAT trial. I would choose BAT now and maybe take part in the phase II trial of JANX007 when that has begun.
The BiTE trial can extend survival if it works. There is no indication that a BAT trial can extend survival, but it may improve QOL. They are both risky.
Well at least your true to your UserID...... Keep turning ahead!!!
Good Luck, Good Health and Good Humor.
j-o-h-n
Not what you're looking for?
You may also like...
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer
I read about Rusland experience with tandem theraphy.
Does anyone know if this type of tandem...
Lu-177-PSMA-I&T for low volume Metastatic Castration-Resistant Prostate Cancer
they've been doing this in Germany recently. Is anyone familiar with Lu-177-PSMA-I&T for Metastatic...
Veru Reports Positive Clinical Results from VERU-111 Phase 1b/2 Trial in Men with Metastatic Castration-Resistant Prostate Cancer, Advancing
behind the drug, was wonderful and wanted to help my husband any way he could. One of the top...
Castrate resistant prostate cancer
the prognosis is worse now but I’m still trying to remain hopeful. Any advice will be greatly...